13 studies found for: Open Studies | "Respiratory Syncytial Virus Infections"
The Development of a Human Model of Respiratory Syncytial Virus Infection
Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age
Utilization and Compliance of Respiratory Syncytial Virus Monoclonal Antibody Therapy
Safety Study of GS-5806 to Treat Respiratory Syncytial Virus (RSV)
RSV001 - A New Vaccine to Prevent Severe Viral Chest Infections.
Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
|7||Not yet recruiting||
Evaluating the Safety and Immune Response to a Single Dose of a Respiratory Syncytial Virus (RSV) Vaccine in RSV-Seronegative Infants and Children
Respiratory Syncytial Virus - RSV Protocol
Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV)
Prospective, Study for the Use of Palivizumab (Synagis) in High Risk Children in Germany
Evaluating the Safety and Immune Response to a Respiratory Syncytial Virus (RSV) Vaccine in Adults, RSV-Seropositive Children, and RSV-Seronegative Infants and Children
TGF-(Beta) and Susceptibility to RSV
RSV Disease in the Elderly
† Indicates status has not been verified in more than two years